Reich, K., Kristensen, L. E., Smith, S. D. ., Rich, P., Sapin, C., Liu Leage, S., … Gooderham, M. (2022). Efficacy and safety of ixekizumab versus adalimumab in patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomised SPIRIT-H2H trial. Dermatology Practical & Conceptual, 12(2), e2022104. https://doi.org/10.5826/dpc.1202a104